相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development and characterization of high payload combination dry powders of anti-tubercular drugs for treating pulmonary tuberculosis
Basanth Babu Eedara et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Co-spray drying of hygroscopic kanamycin with the hydrophobic drug rifampicin to improve the aerosolization of kanamycin powder for treating respiratory infections
Mohammad A. M. Momin et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Manipulation of spray-drying conditions to develop dry powder particles with surfaces enriched in hydrophobic material to achieve high aerosolization of a hygroscopic drug
Mohammad A. M. Momin et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Formulation techniques for high dose dry powders
Ashlee D. Brunaugh et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Preparation and optimization of a dry powder for inhalation of second-line anti-tuberculosis drugs
Rajeev Ranjan et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders
Jiaqi Yu et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update
Dennis Falzon et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Dry powder formulation of kanamycin with enhanced aerosolization efficiency for drug-resistant tuberculosis
Mohammad A. M. Momin et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
How Much Surface Coating of Hydrophobic Azithromycin Is Sufficient to Prevent Moisture-Induced Decrease in Aerosolisation of Hygroscopic Amorphous Colistin Powder?
Qi (Tony) Zhou et al.
AAPS JOURNAL (2016)
Enhanced Bioavailability in the Oxalate Salt of the Anti-Tuberculosis Drug Ethionamide
M. K. Chaitanya Mannava et al.
CRYSTAL GROWTH & DESIGN (2016)
Relationship between surface concentration of L-leucine and bulk powder properties in spray dried formulations
Sharad Mangal et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
Andre F. S. Amaral et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Synergistic Antibiotic Combination Powders of Colistin and Rifampicin Provide High Aerosolization Efficiency and Moisture Protection
Qi (Tony) Zhou et al.
AAPS JOURNAL (2014)
Dry powders for oral inhalation free of lactose carrier particles
Anne Marie Healy et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
How can we bring high drug doses to the lung?
Sarah Claus et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)
A Rifapentine-Containing Inhaled Triple Antibiotic Formulation for Rapid Treatment of Tubercular Infection
John Gar Yan Chan et al.
PHARMACEUTICAL RESEARCH (2014)
Engineered Mannitol Ternary Additives Improve Dispersion of Lactose-Salbutamol Sulphate Dry Powder Inhalations
Waseem Kaialy et al.
AAPS JOURNAL (2013)
The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules
Tomas Sou et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2013)
Carrier-free combination for dry powder inhalation of antibiotics in the treatment of lung infections in cystic fibrosis
Gabrielle Pilcer et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Antibiotic resistance-the need for global solutions
Ramanan Laxminarayan et al.
LANCET INFECTIOUS DISEASES (2013)
A Systematic Review of the Association between Pulmonary Tuberculosis and the Development of Chronic Airflow Obstruction in Adults
Brian W. Allwood et al.
RESPIRATION (2013)
Pharmacokinetics of Sequential Doses of Capreomycin Powder for Inhalation in Guinea Pigs
L. Garcia-Contreras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Formulation and in vivo evaluation of sodium alendronate spray-dried microparticles intended for lung delivery
Leticia Cruz et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Mechanism of Dissolution Enhancement and Bioavailability of Poorly Water Soluble Celecoxib by Preparing Stable Amorphous Nanoparticles
Yinghui Liu et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2010)
Sublethal Antibiotic Treatment Leads to Multidrug Resistance via Radical-Induced Mutagenesis
Michael A. Kohanski et al.
MOLECULAR CELL (2010)
Inhalation Performance of Physically Mixed Dry Powders Evaluated with a Simple Simulator for Human Inspiratory Flow Patterns
Daiki Hira et al.
PHARMACEUTICAL RESEARCH (2010)
Spray-Dried Carrier-Free Dry Powder Tobramycin Formulations With Improved Dispersion Properties
Gabrielle Pilcer et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Inhaled Drug Delivery for Tuberculosis Therapy
Pavan Muttil et al.
PHARMACEUTICAL RESEARCH (2009)
Effect of particle size of dry powder mannitol on the lung deposition in healthy volunteers
William Glover et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Dry powder platform for pulmonary drug delivery
Derek Ivan Daniher et al.
PARTICUOLOGY (2008)
Pharmaceutical particle engineering via spray drying
Reinhard Vehring
PHARMACEUTICAL RESEARCH (2008)
Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America
A. M. B. Menezes et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Amino acid-modified spray-dried powders with enhanced aerosolisation properties for pulmonary drug delivery
P. C. Seville et al.
POWDER TECHNOLOGY (2007)
Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method
Yu You et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2007)
Physical characterization of component particles included in dry powder inhalers. II. Dynamic characteristics
Anthony J. Hickey et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Aerosolised antibacterials for the prevention and treatment of hospital-acquired pneumonia
G. Christopher Wood et al.
DRUGS (2007)
Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis
William J. Burman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Impact of formulation and methods of pulmonary delivery on absorption of parathyroid hormone (1-34) from rat lungs
V Codrons et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Alternative sugars as potential carriers for dry powder inhalations
H Steckel et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis
YM Hu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Lung function in patients with chronic airflow obstruction due to tuberculous destroyed lung
JH Lee et al.
RESPIRATORY MEDICINE (2003)
Activities of moxifloxacin alone and in combination with other antimicrobial agents against multidrug-resistant Mycobacterium tuberculosis infection in BALB/c mice
L Fattorini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
The inhalers of the future? A review of dry powder devices on the market today
IJ Smith et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2003)
On the mechanisms of surface formation and the surface compositions of industrial milk powders
EHJ Kim et al.
DRYING TECHNOLOGY (2003)
The influence of relative humidity on particulate interactions in carrier-based dry powder inhaler formulations
R Price et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2002)
Enhanced pulmonary delivery of insulin by lung lavage fluid and phospholipids
R Mitra et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2001)
Pharmacokinetics of ethionamide administered under fasting conditions or with orange juice, food, or antacids
B Auclair et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
分享论文
